• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性淋巴细胞性甲状腺炎对甲状腺乳头状癌诊断及术中处理的影响

Impact of chronic lymphocytic thyroiditis on the diagnostic and intraoperative management of papillary thyroid cancer.

作者信息

Vaghaiwalla Tanaz M, DeTrolio Victoria, Saghira Cima, Akcin Mehmet, Chen Cheng-Bang, McGillicuddy Christel M, Lew John I

机构信息

Division of Endocrine Surgery, DeWitt Daughtry Department of Surgery, University of Miami Miller School of Medicine, FL; DeWitt Daughtry Family Department of Surgery, University of Miami Leonard M. Miller School of Medicine, FL.

Division of Endocrine Surgery, DeWitt Daughtry Department of Surgery, University of Miami Miller School of Medicine, FL.

出版信息

Surgery. 2025 Mar;179:108937. doi: 10.1016/j.surg.2024.09.050. Epub 2024 Dec 16.

DOI:10.1016/j.surg.2024.09.050
PMID:39690015
Abstract

BACKGROUND

Chronic lymphocytic thyroiditis is an autoimmune thyroid disorder and the most common cause of hypothyroidism in women. Many studies suggest that chronic lymphocytic thyroiditis contributes to a diagnostic challenge in thyroid nodules and may increase the risk of developing papillary thyroid cancer. This study examines preoperative clinical factors and tumor characteristics associated with papillary thyroid cancer among patients with chronic lymphocytic thyroiditis.

METHODS

A retrospective review of prospectively collected data of patients who underwent total thyroidectomy between 2009 and 2020 at a tertiary institution was performed. Sociodemographic factors, comorbidities, surgeon-performed ultrasound, fine needle aspiration, tumor characteristics, and final histopathology were studied. Patients were subdivided into 2 groups based on final histopathology: chronic lymphocytic thyroiditis alone and chronic lymphocytic thyroiditis with papillary thyroid cancer. χ tests were used for independence among categorical variables, and comparisons were based on t tests.

RESULTS

Of 2,200 total thyroidectomy patients, the majority of 250 patients with chronic lymphocytic thyroiditis were women (90.4%) and had a mean age of 50 (±13) years. All patients with chronic lymphocytic thyroiditis underwent preoperative ultrasound, 89.2% (n = 223) underwent fine needle aspiration preoperatively, and 25.2% (n = 63) presented with obstructive symptoms, whereas 53.6% (n = 134) had papillary thyroid cancer on final histopathology and 74.8% (n = 187) underwent central neck lymph node removal. When comparing patients with chronic lymphocytic thyroiditis alone with those with chronic lymphocytic thyroiditis and papillary thyroid cancer, no differences for sex, race, nodule density, nodule size, echogenicity, irregular borders, and number of nodules were identified, but there was a statistically significant difference for obstructive symptoms (37.1% vs 14.9%), multinodular goiter (55.8% vs 32.3%), microcalcifications (18.4% vs 36.6%), Bethesda III fine needle aspiration results (41.4% vs 27.4%), and central neck lymph node removal (58.6% vs 88.8%), respectively (P < .05). Preoperative fine needle aspiration in patients with chronic lymphocytic thyroiditis for papillary thyroid cancer had a positive predictive value of 92.9%, negative predictive value of 83.3%, false positive rate of 13.8%, and false negative rate of 8.8%.

CONCLUSION

Although thyroid ultrasound features may have limited utility for malignancy, fine needle aspiration of index thyroid nodules still demonstrates a high positive predictive value in stratifying patients with chronic lymphocytic thyroiditis with papillary thyroid cancer. A higher level of suspicion preoperatively may be needed to avoid unnecessary lymph node removal for patients with chronic lymphocytic thyroiditis.

摘要

背景

慢性淋巴细胞性甲状腺炎是一种自身免疫性甲状腺疾病,是女性甲状腺功能减退最常见的原因。许多研究表明,慢性淋巴细胞性甲状腺炎给甲状腺结节的诊断带来挑战,并可能增加患甲状腺乳头状癌的风险。本研究探讨慢性淋巴细胞性甲状腺炎患者中与甲状腺乳头状癌相关的术前临床因素和肿瘤特征。

方法

对一家三级医疗机构2009年至2020年间接受全甲状腺切除术患者的前瞻性收集数据进行回顾性分析。研究了社会人口统计学因素、合并症、外科医生进行的超声检查、细针穿刺活检、肿瘤特征和最终组织病理学。根据最终组织病理学将患者分为两组:单纯慢性淋巴细胞性甲状腺炎组和慢性淋巴细胞性甲状腺炎合并甲状腺乳头状癌组。χ检验用于分类变量间的独立性检验,比较基于t检验。

结果

在2200例全甲状腺切除术患者中,250例慢性淋巴细胞性甲状腺炎患者多数为女性(90.4%),平均年龄50(±13)岁。所有慢性淋巴细胞性甲状腺炎患者均接受了术前超声检查,89.2%(n = 223)患者术前接受了细针穿刺活检,25.2%(n = 63)患者出现阻塞性症状,而最终组织病理学检查显示53.6%(n = 134)患者患有甲状腺乳头状癌,74.8%(n = 187)患者接受了中央区颈部淋巴结清扫术。将单纯慢性淋巴细胞性甲状腺炎患者与慢性淋巴细胞性甲状腺炎合并甲状腺乳头状癌患者进行比较,在性别、种族、结节密度、结节大小、回声、边界不规则和结节数量方面未发现差异,但在阻塞性症状(37.1%对14.9%)、多结节性甲状腺肿(55.8%对32.3%)、微钙化(18.4%对36.6%)、贝塞斯达III级细针穿刺活检结果(41.4%对27.4%)和中央区颈部淋巴结清扫术(58.6%对88.8%)方面分别存在统计学显著差异(P < 0.05)。慢性淋巴细胞性甲状腺炎患者术前细针穿刺活检诊断甲状腺乳头状癌阳性预测值为92.9%,阴性预测值为83.3%,假阳性率为13.8%,假阴性率为8.8%。

结论

尽管甲状腺超声特征对判断恶性肿瘤的作用可能有限,但对甲状腺索引结节进行细针穿刺活检在对慢性淋巴细胞性甲状腺炎合并甲状腺乳头状癌患者进行分层时仍显示出较高的阳性预测值。对于慢性淋巴细胞性甲状腺炎患者,术前可能需要更高的怀疑度以避免不必要的淋巴结清扫。

相似文献

1
Impact of chronic lymphocytic thyroiditis on the diagnostic and intraoperative management of papillary thyroid cancer.慢性淋巴细胞性甲状腺炎对甲状腺乳头状癌诊断及术中处理的影响
Surgery. 2025 Mar;179:108937. doi: 10.1016/j.surg.2024.09.050. Epub 2024 Dec 16.
2
Clinical impact of coexistent chronic lymphocytic thyroiditis on central lymph node metastasis in low- to intermediate-risk papillary thyroid carcinoma: The MASTER study.并存的慢性淋巴细胞性甲状腺炎对低至中危乳头状甲状腺癌中央淋巴结转移的临床影响:MASTER研究
Surgery. 2024 Apr;175(4):1049-1054. doi: 10.1016/j.surg.2023.12.023. Epub 2024 Jan 27.
3
Correlation of thyroid fine-needle aspiration with final histopathology: a case series.甲状腺细针穿刺与最终组织病理学的相关性:病例系列
Minerva Chir. 2013 Apr;68(2):191-7.
4
The reliability of fine-needle aspiration biopsy in terms of malignancy in patients with Hashimoto thyroiditis.细针穿刺活检在桥本甲状腺炎患者中判断恶性肿瘤方面的可靠性。
Int Surg. 2015 Feb;100(2):249-53. doi: 10.9738/INTSURG-D-13-00209.1.
5
Malignancy Rate of Bethesda Class III Thyroid Nodules Based on the Presence of Chronic Lymphocytic Thyroiditis in Surgical Patients.基于手术患者中慢性淋巴细胞性甲状腺炎的存在,贝塞斯达分类法 III 级甲状腺结节的恶性率。
Front Endocrinol (Lausanne). 2021 Sep 30;12:745395. doi: 10.3389/fendo.2021.745395. eCollection 2021.
6
Sonographic Characteristics of Papillary Thyroid Carcinoma With Coexistent Hashimoto's Thyroiditis in the Preoperative Prediction of Central Lymph Node Metastasis.桥本甲状腺炎合并甲状腺乳头状癌的术前超声特征对中央区淋巴结转移的预测。
Front Endocrinol (Lausanne). 2021 Mar 15;12:556851. doi: 10.3389/fendo.2021.556851. eCollection 2021.
7
Incidentally Discovered Papillary Thyroid Microcarcinomas Are More Frequently Found in Patients with Chronic Lymphocytic Thyroiditis Than with Multinodular Goiter or Graves' Disease.偶然发现的甲状腺微小乳头状癌在慢性淋巴细胞性甲状腺炎患者中比在多结节性甲状腺肿或格雷夫斯病患者中更为常见。
Thyroid. 2020 Apr;30(4):531-535. doi: 10.1089/thy.2019.0347. Epub 2020 Feb 20.
8
False-positive cytopathology results for papillary thyroid carcinoma: A trap for thyroid surgeons.甲状腺乳头状癌的细胞病理学假阳性结果:甲状腺外科医生面临的陷阱
Clin Otolaryngol. 2017 Dec;42(6):1153-1160. doi: 10.1111/coa.12840. Epub 2017 Feb 26.
9
High TPOAb Levels (>1300 IU/mL) Indicate Multifocal PTC in Hashimoto's Thyroiditis Patients and Support Total Thyroidectomy.高甲状腺过氧化物酶抗体水平(>1300 IU/mL)提示桥本甲状腺炎患者存在多灶性乳头状甲状腺癌,并支持行甲状腺全切除术。
Otolaryngol Head Neck Surg. 2015 Jul;153(1):20-6. doi: 10.1177/0194599815581831. Epub 2015 Apr 27.
10
Cytopathology-histopathology correlation and the effect of nodule diameter on diagnostic performance in patients undergoing thyroid fine-needle aspiration biopsy.细胞学-组织病理学相关性及结节直径对甲状腺细针抽吸活检患者诊断性能的影响。
J Cancer Res Ther. 2020 Dec;16(Supplement):S53-S58. doi: 10.4103/jcrt.JCRT_219_18.

引用本文的文献

1
Association of thyroglobulin antibody and thyroid peroxidase antibody status with aggressive features in papillary thyroid carcinoma with Hashimoto's thyroiditis.甲状腺球蛋白抗体和甲状腺过氧化物酶抗体状态与合并桥本甲状腺炎的乳头状甲状腺癌侵袭性特征的关联
Gland Surg. 2025 Jun 30;14(6):1091-1100. doi: 10.21037/gs-2025-47. Epub 2025 Jun 26.
2
Risk Stratification for Thyroid Malignancies in Chronic Lymphocytic Thyroiditis.慢性淋巴细胞性甲状腺炎中甲状腺恶性肿瘤的风险分层
Cancers (Basel). 2025 Jun 12;17(12):1964. doi: 10.3390/cancers17121964.